Table 6.
Variables Significantly Associated with NIs in the Study Groups
| NI n = 14 |
Non-NI n = 106 |
P Value | |
|---|---|---|---|
| Baseline creatinine (mg/dL) | 1.5 (8.9-0.6) | 0.95 (8-0.35) | .03* |
| Baseline eGFR (mL/min) | 56.79 ± 27.1 | 71.77 ± 27.88 | .04* |
| IL-6 (pg/mL) | 89.3 (1682-3.2) | 24.2 (1004.6-1) | .01* |
| D-dimer | 412 (46768-168) | 251.5 (19313-80) | .01* |
| MULBSTA score | 12.84 ± 3.97 | 9.21 ± 3.93 | .002* |
| ICU admission | 9 (64.3) | 10 (9.43) | < .001* |
| Shock n (%) | 6 (42.9) | 5 (4.71) | < .001* |
| Ventilatory support/O2 therapy n (%) | |||
| High flow nasal cannula O2 | 4 (28.6) | 26 (76.47) | < .001* |
| Non-invasive mechanical ventilation | 0 (0) | 7 (20.59) | |
| Invasive mechanical ventilation | 5 (35.7) | 1 (2.94) | |
| AKI during follow-up n (%) | 8 (57.1) | 7 (6.7) | < .001* |
| CVVHD/HD n (%) | 3 (21.4) | 2 (1.9) | .001* |
| Concomitant infection n (%) | 8 (57.1) | 25 (23.58) | .009* |
| Final creatinine (mg/dL) | 2.02 ± 2.22 | 1.15 ± 0.96 | 0.01* |
| Hospitalization time (d) | 25 (90-6) | 7 (35-1) | < .001* |
| ICU time (d) | 25.44 ± 16.11 | 8.36 ± 4.94 | .004* |
AKI, acute kidney injury; CVVHD, continuous veno-venous hemodialysis; eGFR, estimated glomerular filtration rate; HD, hemodialysis; ICU, intensive care unit; IL, interleukin; NI, nosocomial infection.
⁎
P < .05.